Immunitybio Inc (IBRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Sales | 16,517 | 7,552 | 6,106 | 1,047 | 40 |
| Cost of Goods | 58 | N/A | N/A | N/A | N/A |
| Gross Profit | 16,459 | 7,552 | 6,106 | 1,047 | 40 |
| Operating Expenses | 80,946 | 76,952 | 86,359 | 100,380 | 95,236 |
| Operating Income | -64,429 | -69,400 | -80,253 | -99,333 | -95,196 |
| Interest Expense | 27,978 | 37,574 | 40,247 | 39,019 | 37,487 |
| Other Income | -37,493 | 47,795 | 34,748 | 3,768 | -1,447 |
| Pre-tax Income | -129,900 | -59,179 | -85,752 | -134,584 | -134,130 |
| Income Tax | -234 | N/A | N/A | N/A | N/A |
| Net Income Continuous | -129,666 | -59,179 | -85,752 | -134,584 | -134,130 |
| Minority Interests | -20 | -17 | -23 | -20 | -21 |
| Net Income | $-129,646 | $-59,162 | $-85,729 | $-134,564 | $-134,109 |
| EPS Basic Total Ops | -0.15 | -0.07 | -0.12 | -0.20 | -0.20 |
| EPS Basic Continuous Ops | -0.15 | -0.07 | -0.12 | -0.20 | -0.20 |
| EPS Diluted Total Ops | -0.15 | -0.08 | -0.14 | -0.20 | -0.20 |
| EPS Diluted Continuous Ops | -0.15 | -0.07 | -0.12 | -0.20 | -0.20 |
| EPS Diluted Before Non-Recurring Items | -0.15 | -0.15 | -0.14 | N/A | N/A |
| EBITDA(a) | $-60,652 | $-60,255 | $-69,599 | $-88,604 | $-85,583 |